Jordan vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Jordan
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Jordan rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Jordan
- South-East Asia (WHO region)
How they compare
Jordan currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Jordan's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 6 years both countries report, Jordan has been ahead every year.
Jordan ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jordan | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 17.0% | 83.0% | Jordan |
| 2010s | 100.0% | 77.3% | 22.7% | Jordan |
| 2020s | 100.0% | 94.0% | 6.0% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Jordan or South-East Asia (WHO region)?
- Jordan, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Jordan and South-East Asia (WHO region)?
- 6.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and South-East Asia (WHO region)?
- 6 years are reported by both, from 2007 to 2024.
- How do Jordan and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Jordan ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.